Tenet Q4 net income $102M ($0.92 diluted EPS), FY2023 Adj. EBITDA guidance $3.16B-$3.36B

TENET HEALTHCARE CORP

2022-FY EPS reported $3.79 revenue$19,174,000,000

Q4 2022 net income from continuing ops $102M ($0.92 diluted EPS) vs $250M ($2.30) a year ago; adjusted diluted EPS $1.96 vs $2.70.
Consolidated Q4 Adj. EBITDA $897M (incl $40M grant income) vs $1.017B; Ambulatory Adj. EBITDA ex-grant grew 18.7% to $407M.
FY2023 outlook: Adj. EBITDA $3.16B-$3.36B, adjusted diluted EPS $4.68-$5.85; net operating revenues $19.7B-$20.1B.
Repurchased 5.9M shares for $250M in Q4; entered deal to sell San Ramon Regional Medical Center for $142.5M (close expected 2023).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TENET HEALTHCARE CORP reported quarter ended December 31, 2022 results: revenue $4,990, net income $102 million, EPS $0.92 per diluted share.

Period: quarter ended December 31, 2022
Revenue: $4,990
Net income: $102 million
EPS: $0.92 per diluted share
Result: reported results

Exact text from the filing

2021 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2022 2021 2022 2021 Net operating revenues $4,990 $4,856 $19,174 $19,485 Net income available to Tenet common shareholders from continuing operations $102 $250 $410 $915 Net income available to Tenet common shareholders from

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

TENET HEALTHCARE CORP filing history →

Source: SEC EDGAR

accession 0000070318-23-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.